Natco Pharma’s Partner Mylan Inc Gets USFDA Approval For Cancer Drug

Mylan Inc has received a tentative approval from the USFDA for abbreviated new drug application for Sorafenib tablets in the strength of 200 mg. New Delhi:¬†Natco Pharma on Friday said its marketing partner Mylan Inc has received tentative approval from the US health regulator for selling generic Sorafenib tablets used […]

Cipla completes $550 million acquisition of 2 US generic drug companies

Cipla has compled its $ 550-million (around Rs 3575 crore) acquisition of US generic drug makers InvaGen and Exelan. This gives the 80-year-old Indian drug maker a bigger presence in the lucrative US market. This is its second major acquisition after the Rs 2,700-crore deal to buy South African drug […]